Figures & data
Figure 1 Flowchart describing the inclusion of patients.
![Figure 1 Flowchart describing the inclusion of patients.](/cms/asset/9e342a5a-cff2-42fb-acd1-f9a1120a35b8/dceo_a_55899_f0001_b.jpg)
Table 1 Patients’ baseline and intraoperative characteristics
Figure 3 Observed EQ-5D utility scores in the complete dataset.
Abbreviaton: EQ-5D, EuroQol 5 Dimensions questionnaire.
![Figure 3 Observed EQ-5D utility scores in the complete dataset.Abbreviaton: EQ-5D, EuroQol 5 Dimensions questionnaire.](/cms/asset/aaed2a19-b579-4f4e-b33c-67c5aeac5418/dceo_a_55899_f0003_b.jpg)
Table 2 Mean utility and VAS scores for all observations
Figure 4 Mean observed and predicted EQ-5D utility scores in the validation sample.
Abbreviation: EQ-5D, EuroQol 5 Dimensions questionnaire.
![Figure 4 Mean observed and predicted EQ-5D utility scores in the validation sample.](/cms/asset/d0909742-f328-45f3-9887-75d0f69864bf/dceo_a_55899_f0004_b.jpg)
Table 3 Results of the estimated mapping-models
Table 4 Mean absolute error of mapping-models at subsets of observed EQ-5D utility scores
Figure 5 Bland–Altman plots of agreement between observed and predicted EQ-5D utility scores.
Abbreviations: EQ-5D, EuroQol 5 Dimensions questionnaire; SD, standard deviation.
![Figure 5 Bland–Altman plots of agreement between observed and predicted EQ-5D utility scores.](/cms/asset/b7a5c4f4-9a4a-43a6-8f60-4aceb6e7b0eb/dceo_a_55899_f0005_b.jpg)